ONO-2952 clinical trials
Also written ONO-2952.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How each study uses ONO-2952 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ONO-2952
- 5
Studies by the year they started
5 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses ONO-2952 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)CompletedPhase 2Ono Pharma USA IncNCT01844180Written as ONO-2952How we know
- Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)TerminatedPhase 2Ono Pharma USA IncNCT01887002Written as ONO-2952How we know
- ONO-2952 Single-dose PET Study in Healthy Adult SubjectsCompletedPhase 1Ono Pharma USA IncNCT01613703Written as ONO-2952How we know
- Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult SubjectsCompletedPhase 1Ono Pharma USA IncNCT01489345Written as ONO-2952How we know
- Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult SubjectsCompletedPhase 1Ono Pharma USA IncNCT01364441Written as ONO-2952How we know